Recurrence of Hepatocellular Carcinoma after Liver Transplantation: Clinical Patterns and Hierarchy of Salvage Treatments
Digestive Surgery · 2024
DOI: 10.1159/000539460 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive Surgery, 2024. Verfasst von Tommaso Giuliani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Unit of HPB Surgery and Transplantation, La Fe University Hospital and University of Valencia, Valencia, Spain, tommasogiuliani@gmail.com. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Transplantation, Liver Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Introduction
The multiparametric nature of recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT) still leads to uncertainty with its practical management. This study aims to characterize the main posttransplant recurrence patterns of HCC and to explore the therapeutic modalities targeting recurrence.
Methods
Consecutive patients who underwent LT for HCC at a single tertiary center were analyzed. The time from first recurrence to death was investigated for each site of presentation. The impact of each recurrence-targeted treatment on survival was studied.
Results
Of 660 patients with HCC, any recurrence occurred in 96 (15.4%) patients with a median time to recurrence of 20.0 months (95% CI: 15.6–23.8). Patients recurred across different patters including solitary distant locations (30.8%, n = 28), liver only (24.2%, n = 22), lung (18.7%, n = 17), multi-organ disease (17.6%, n = 16), and bone (8.8%, n = 8). Multi-organ and bone recurrences had the poorest survival, while solitary distant lesions and pulmonary recurrences had the best outcomes. Each treatment modality carried a distinctive survival.
Conclusions
Patients recurred across 3 patterns with different prognostic implications. The benefit of each treatment option on distinct recurrence patterns appears to be influenced by the biological behavior inherent in the recurrence pattern itself.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unit of HPB Surgery and Transplantation, La Fe University Hospital and University of Valencia, Valencia, Spain, tommasogiuliani@gmail.com.
- Unit of HPB Surgery and Transplantation, La Fe University Hospital and University of Valencia, Valencia, Spain.
- IIS La Fe (Valencia), Ciberehd, Instituto de Salud Carlos III, Madrid, Spain.
- Unit of Radiology, La Fe University Hospital and University of Valencia, Valencia, Spain.
- Unit of Hepatology, La Fe University Hospital and University of Valencia, Valencia, Spain.
Zitieren
APA
Giuliani, T., Montalvá, E., Maupoey, J., Boscá, A., Hernando, A., Calatayud, D., Navarro, V., Rubín, A., Vinaixa, C., & López-Andújar, R. (2024). Recurrence of Hepatocellular Carcinoma after Liver Transplantation: Clinical Patterns and Hierarchy of Salvage Treatments. Digestive Surgery. https://doi.org/10.1159/000539460
Vancouver
Giuliani T, Montalvá E, Maupoey J, Boscá A, Hernando A, Calatayud D, et al. Recurrence of Hepatocellular Carcinoma after Liver Transplantation: Clinical Patterns and Hierarchy of Salvage Treatments. Digestive Surgery. 2024. doi:10.1159/000539460
BibTeX
@article{Giuliani2024,
author = {Giuliani, Tommaso and Montalvá, Eva and Maupoey, Javier and Boscá, Andrea and Hernando, Ana and Calatayud, David and Navarro, Vicente and Rubín, Angel and Vinaixa, Carmen and López-Andújar, Rafael},
title = {Recurrence of Hepatocellular Carcinoma after Liver Transplantation: Clinical Patterns and Hierarchy of Salvage Treatments},
journal = {Digestive Surgery},
year = {2024},
doi = {10.1159/000539460}
}
EUVIMED